Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

CPH/CHEMM stock hub

CPH/CHEMM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CPH/CHEMMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.5B

Copenhagen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CPH/CHEMM

In the news

Latest news · CPH/CHEMM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E26.7

P25 14.6P50 19.5P75 24.2

Trailing P/E31

P25 11.8P50 20.8P75 32.9

ROE28.3

P25 -4.6P50 11.3P75 24.2

ROIC46.7

P25 -8.1P50 8.5P75 13.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CPH/CHEMM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

240

Groups with data

Currency

DKK

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Denmark
Country code	DK
Employees	172
Employees Change	2%
Employees Change Percent	1.18
Enterprise value	DKK 5.2B
Exchange	Copenhagen Stock Exchange
Financial currency	DKK
First seen	2026-05-10
Industry	Medical Devices
Isin	DK0060055861
Last refreshed	2026-05-10
Market cap	DKK 5.5B
Price	DKK 315
Price currency	DKK
Rev Per Employee	2,866,947.67x
Sector	Healthcare
Sic	3845
Symbol	cph/CHEMM
Website	https://chemometec.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.23%
EV Earnings	29.42x
EV/EBIT	22.54x
EV/EBITDA	21.33x
EV/FCF	29.06x
EV/Sales	10.56x
FCF yield	3.27%
Forward P/E	26.71x
P/B ratio	8.39x
P/E ratio	30.95x
P/S ratio	11.11x
PE Ratio10 Y	72.69x
PE Ratio3 Y	54.48x
PE Ratio5 Y	50.17x
PEG ratio	2.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	46.86%
EBITDA Margin	49.51%
FCF margin	36.35%
Gross margin	95.54%
Gross Profit	DKK 471.1M
Gross Profit Growth	1.21%
Gross Profit Growth Q	2.44%
Gross Profit Growth3 Y	8.62%
Gross Profit Growth5 Y	2.74%
Net Income	DKK 177M
Net Income Growth	4.7%
Net Income Growth Q	-9.07%
Net Income Growth Years	1%
Net Income Growth3 Y	9.11%
Net Income Growth5 Y	-0.18%
Pretax Margin	46.37%
Profit Margin	35.9%
Profit Per Employee	DKK 1M
Profitable Years	13
ROA	19.08
Roa5y	22.83
ROCE	35.01
ROE	28.31
Roe5y	36.82
ROIC	46.7
Roic5y	80.94

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	26.6%
Cagr15y	32.07%
Cagr1y	-29.72%
Cagr3y	-6.16%
Cagr5y	-12.77%
Div CAGR3	5.27%
Div CAGR5	11.84%
EPS Growth	4.62
EPS Growth Q	-9.09
EPS Growth Years	1
EPS Growth3 Y	9.11
EPS Growth5 Y	-0.19
FCF Growth	17.78%
FCF Growth Q	2.12%
FCF Growth3 Y	18.37%
FCF Growth5 Y	6.15%
OCF Growth	19.22%
OCF Growth Q	2.99%
OCF Growth10 Y	7.42%
OCF Growth3 Y	17.65%
OCF Growth5 Y	6.39%
Revenue Growth	7.31x
Revenue Growth Q	-0.98x
Revenue Growth Years	1x
Revenue Growth3 Y	6.53x
Revenue Growth5 Y	2.1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	DKK 0.65
Assets	DKK 783.4M
Cash	DKK 274.7M
Current Assets	DKK 484.4M
Current Liabilities	DKK 123.3M
Debt	DKK 5.2M
Debt EBITDA	DKK 0.02
Debt Equity	DKK 0.01
Debt FCF	DKK 0.03
Equity	DKK 652.6M
Interest Coverage	172.8
Liabilities	DKK 130.8M
Long Term Assets	DKK 298.9M
Long Term Liabilities	DKK 7.5M
Net Cash	DKK 269.5M
Net Cash By Market Cap	DKK 4.92
Net Cash Growth	4.86%
Net Debt EBITDA	DKK -1.1
Net Debt Equity	DKK -0.41
Net Debt FCF	DKK -1.5
Tangible Book Value	DKK 484.7M
Tangible Book Value Per Share	DKK 27.85
WACC	11.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.93
Inventory Turnover	0.18
Net Working Capital	DKK 88.9M
Quick ratio	3.02
Working Capital	DKK 361.2M
Working Capital Turnover	DKK 1.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.07%
Dividend Growth	75%
Dividend Growth Years	1%
Dividend per share	DKK 7
Dividend Years	3
Dividend Yield	2.22%
Ex Div Date	2025-10-10
Last Dividend	DKK 7
Payout Frequency	Annual
Payout Ratio	68.81%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	956.86%
1Y total return	-29.7%
200-day SMA	556.3
3Y total return	-17.38%
50-day SMA	349.5
50-day SMA vs 200-day SMA	50under200
5Y total return	-49.49%
All Time High	1,149
All Time High Change	-72.6%
All Time High Date	2021-09-23
All Time Low	3.15
All Time Low Change	9,893.65%
All Time Low Date	2012-12-10
ATR	16.81
Beta	1.33
Beta1y	1.05
Beta2y	1.07
Ch YTD	-54.21
High	323.2
High52	804
High52 Date	2025-10-30
High52ch	-60.85%
Low	313.2
Low52	235.2
Low52 Date	2026-03-24
Low52ch	33.84%
Ma50ch	-9.93%
Price vs 200-day SMA	-43.41%
RSI	42.96
RSI Monthly	39.67
RSI Weekly	31.04
Sharpe ratio	-0.37x
Sortino ratio	-0.38
Total Return	2.15%
Tr YTD	-54.21
Tr15y	6,389.5%
Tr1m	7.29%
Tr1w	-3.44%
Tr3m	-27.13%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	DKK 231.1M
Operating Income Growth	-2.3
Operating Income Growth Q	-4.32
Operating Income Growth3 Y	11
Operating Income Growth5 Y	0.04
Operating margin	46.86

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	16,745,378%
Net Borrowing	1,516,000
Shares Insiders	3.78%
Shares Institutions	32.94%
Shares Out	17,402,479
Shares Qo Q	-0.02%
Shares Yo Y	0.07%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	DKK 179.2M
Average Volume	78,821.25x
Bv Per Share	37.5
CAPEX	DKK -30.8M
Ch10y	799.4
Ch15y	5,422.8
Ch1m	7.29
Ch1w	-3.44
Ch1y	-30.42
Ch3m	-27.13
Ch3y	-20.59
Ch5y	-51.68
Ch6m	-54.64
Change	-2.3%
Change From Open	-1.93
Close	322.2
Days Gap	-0.37
Depreciation Amortization	13,085,000
Dollar Volume	17,534,045.2
Earnings Date	2026-09-10
EBIT	DKK 231.1M
EBITDA	DKK 244.2M
EPS	DKK 10.17
F Score	6
FCF	DKK 179.2M
FCF EV Yield	3.44x
FCF Per Share	DKK 10.3
Financing CF	-120,301,000
Fiscal Year End	June
Founded	1,997
Goodwill	7,358,000
Graham Number	92.63496
Graham Upside	-70.57
Income Tax	DKK 51.6M
Investing CF	-77,328,000
Is Primary Listing	1
Last Earnings Date	2026-02-04
Last Report Date	2025-12-31
Lynch Fair Value	DKK 50.85
Lynch Upside	-83.85
Ma150	559.7
Ma150ch	-43.76%
Ma20	326.5
Ma20ch	-3.59%
Net CF	9,927,000
Next Earnings Date	2026-09-10
Open	321
P FCF Ratio	30.57
P OCF Ratio	26.08
Payment Date	2025-10-14
Position In Range	16
Ppne	119,627,000
Price Date	2026-05-08
Price EBITDA	DKK 22.44
Ptbv Ratio	11.3
Relative Volume	0.72x
Revenue	493,115,000x
Tax By Revenue	10.47x
Tax Rate	22.58%
Tr6m	-54.64%
Volume	55,699
Z Score	49.32

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

CPH/CHEMM dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.2%

$7.00 annual per share

Payout ratio

+68.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+11.8%

1 consecutive years of growth

Total shareholder yield

+2.2%

Next ex-dividend date: 2025-10-10

Performance

CPH/CHEMM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CPH/CHEMM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+32.9%

Share of float held by funds and institutions

Insider ownership

+3.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

CPH/CHEMM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.0

Neutral momentum band

Price vs 200-day MA

-43.4%

50/200-day relationship not available

Beta (5Y)

1.33

More volatile than the market

Sharpe ratio

-0.37

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CPH/CHEMM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cph/CHEMM stock rating?

cph/CHEMM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cph/CHEMM analysis?

The full report lives at /stocks/cph/CHEMM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cph/CHEMM?

The latest report frames cph/CHEMM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cph/CHEMM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.